MITO 35a
MITO 35a: a multicenter, prospective, single arm trial of Olaparib maintenance therapy in newly diagnosed BRCA wild-type advanced ovarian, primitive peritoneal, and fallopian tube cancer.
STATO: Raccolta dati ancora in corso
PATOLOGIA: Ovaio
CENTRO COORDINATORE MITO:
PRINCIPAL INVESTIGATOR: Sandro Pignata
CO INVESTIGATOR: -
STUDY COORDINATOR: Clorinda Schettino, Francesco Perrone